Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: overall survival analysis. [electronic resource]
Producer: 20130307Description: 2361-8 p. digitalISSN:- 1879-0852
- Aged
- Antibiotics, Antineoplastic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Ovarian Epithelial
- Dioxoles -- administration & dosage
- Disease-Free Survival
- Doxorubicin -- administration & dosage
- Female
- Humans
- Middle Aged
- Neoplasm Recurrence, Local
- Neoplasms, Glandular and Epithelial -- drug therapy
- Ovarian Neoplasms -- drug therapy
- Polyethylene Glycols -- administration & dosage
- Survival Analysis
- Tetrahydroisoquinolines -- administration & dosage
- Trabectedin
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.